124 related articles for article (PubMed ID: 24687061)
1. Cancer: Unleashing NK cell anti-metastatic activity.
Flemming A
Nat Rev Drug Discov; 2014 Apr; 13(4):257. PubMed ID: 24687061
[No Abstract] [Full Text] [Related]
2. Signalling: loss of Cbl-b unleashes anti-metastatic natural killer cells.
Lokody I
Nat Rev Cancer; 2014 Apr; 14(4):218. PubMed ID: 24622519
[No Abstract] [Full Text] [Related]
3. Immunotherapy: killing with natural killers, naturally.
Villanueva MT
Nat Rev Clin Oncol; 2014 Apr; 11(4):180. PubMed ID: 24590132
[No Abstract] [Full Text] [Related]
4. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Paolino M; Choidas A; Wallner S; Pranjic B; Uribesalgo I; Loeser S; Jamieson AM; Langdon WY; Ikeda F; Fededa JP; Cronin SJ; Nitsch R; Schultz-Fademrecht C; Eickhoff J; Menninger S; Unger A; Torka R; Gruber T; Hinterleitner R; Baier G; Wolf D; Ullrich A; Klebl BM; Penninger JM
Nature; 2014 Mar; 507(7493):508-12. PubMed ID: 24553136
[TBL] [Abstract][Full Text] [Related]
5. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
[TBL] [Abstract][Full Text] [Related]
6. Malfunctions within the Cbl interactome uncouple receptor tyrosine kinases from destructive transport.
Dikic I; Schmidt MHH
Eur J Cell Biol; 2007 Sep; 86(9):505-12. PubMed ID: 17553592
[TBL] [Abstract][Full Text] [Related]
7. Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase.
Scott RP; Eketjäll S; Aineskog H; Ibáñez CF
J Biol Chem; 2005 Apr; 280(14):13442-9. PubMed ID: 15677445
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.
Guo H; Qiao G; Ying H; Li Z; Zhao Y; Liang Y; Yang L; Lipkowitz S; Penninger JM; Langdon WY; Zhang J
Cell Rep; 2012 May; 1(5):472-82. PubMed ID: 22763434
[TBL] [Abstract][Full Text] [Related]
9. CD16-mediated activation of phosphatidylinositol-3 kinase (PI-3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb2, Shc, pp36 and p85 PI-3K subunit.
Cerboni C; Gismondi A; Palmieri G; Piccoli M; Frati L; Santoni A
Eur J Immunol; 1998 Mar; 28(3):1005-15. PubMed ID: 9541596
[TBL] [Abstract][Full Text] [Related]
10. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
11. c-Cbl is a critical modulator of the Ron tyrosine kinase receptor.
Penengo L; Rubin C; Yarden Y; Gaudino G
Oncogene; 2003 Jun; 22(24):3669-79. PubMed ID: 12802274
[TBL] [Abstract][Full Text] [Related]
12. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
[TBL] [Abstract][Full Text] [Related]
13. Role for adapter proteins in costimulatory signals of CD2 and IL-2 on NK cell activation.
Umehara H; Inoue H; Huang J; Kono T; Minami Y; Tanaka Y; Okazaki T; Mimori T; Bloom ET; Domae N
Mol Immunol; 2002 Jan; 38(8):587-96. PubMed ID: 11792427
[TBL] [Abstract][Full Text] [Related]
14. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
15. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
[TBL] [Abstract][Full Text] [Related]
16. An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance.
Mohapatra B; Zutshi N; An W; Goetz B; Arya P; Bielecki TA; Mushtaq I; Storck MD; Meza JL; Band V; Band H
Development; 2017 Mar; 144(6):1072-1086. PubMed ID: 28100467
[TBL] [Abstract][Full Text] [Related]
17. T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells.
Qiao G; Zhao Y; Li Z; Tang PQ; Langdon WY; Yang T; Zhang J
J Immunol; 2013 Jul; 191(2):632-9. PubMed ID: 23749633
[TBL] [Abstract][Full Text] [Related]
18. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
Sévère N; Dieudonné FX; Marie PJ
Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
[TBL] [Abstract][Full Text] [Related]
19. CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases.
Szymkiewicz I; Kowanetz K; Soubeyran P; Dinarina A; Lipkowitz S; Dikic I
J Biol Chem; 2002 Oct; 277(42):39666-72. PubMed ID: 12177062
[TBL] [Abstract][Full Text] [Related]
20. Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases.
Oved S; Mosesson Y; Zwang Y; Santonico E; Shtiegman K; Marmor MD; Kochupurakkal BS; Katz M; Lavi S; Cesareni G; Yarden Y
J Biol Chem; 2006 Aug; 281(31):21640-21651. PubMed ID: 16735510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
